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Results 
Two hundred seventy-nine discharges were processed during the study 
period. Fifteen TTOs were excluded due to stating ͞Ŷo changes…͟ 
rather than listing medication. Eleven patients (4%, 11/264) died and 
41 patients (16%, 41/253) were readmitted within 30 days. A slight but 
statistically significant association between cardiovascular medication 
prescribed on discharge and readmission was observed (p=0.023, 
φ=0.143): 151 patients were prescribed cardiovascular medication of 
whom 31 (21%, 31/151) were readmitted (fig. 2), compared with  102 
patients not prescribed cardiovascular medication of whom ten (9.8%, 
10/102) were readmitted. 
 
Discussion 
The results demonstrate that information on discharge prescriptions 
could be used by pharmacists conducting prescription validation to 
identify patients at risk of readmission. The findings also indicate where 
efforts to reduce readmissions may be effectively targeted. Further 
work will be undertaken to extend the analysis to include other 
medications, as well as refine the analysis into therapeutic class. The 
next phase of the project will involve evaluating the effectiveness of 
pharmaceutical interventions in reducing readmissions. 
 
 
 
 
 
 
 
 
 
 
 
A preliminary study identifying prescription 
factors associated with readmission 
Sarah Upton a,b, Michael Culshaw a, Margaret Culshaw b, John Stephenson b  
a Calderdale and Huddersfield NHS Foundation Trust, b University of Huddersfield 
Sarah.Upton@hud.ac.uk 
References 
1. van Walraven C, Dhalla IA, Bell C, Etchells E, Stiell IG, Zarnke K, et al. Derivation and validation of an index to predict early death or unplanned readmission 
after discharge from hospital to the community. Canadian Medical Association Journal. 2010;182(6):551-7. 
2. Joint Formulary Committee. British National Formulary: Medicines Complete; 2014 [6th October 2014]. Available from:  
https://www.medicinescomplete.com/mc/bnf/current/PHP747-cardiovascular-system.htm 
Background  
The LACE index (1) is used by Calderdale and Huddersfield NHS 
Foundation Trust to refer patients to a Virtual Ward, providing post 
discharge support with a view to preventing readmissions. Derivation of 
the LACE index found the Charlson comorbidity index (CCI) predictive of 
readmission; conditions in the CCI are likely to be treated with 
medication.  
 
Aim & Objectives 
As part of a project exploring whether prescription information could 
be used to identify patients at risk of readmission, the aim of this study 
was to determine whether prescription of cardiovascular medication at 
discharge is associated with readmission. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: BNF Chapter 2 - Cardiovascular System 
 
Method 
All discharge prescriptions (TTOs) from Calderdale Royal Hospital 
Medical Short Stay Unit between 28th October and 22nd December 
2013 were categorised according to whether cardiovascular 
medication, as listed in BNF Chapter 2 (2) (fig. 1) was prescribed or 
not. TTOs with the clause ͞Ŷo changes to regular ŵedicatioŶ͟ applied 
were excluded due to the absence of a medication list. Patient 
outcome at 30 days was recorded as readmitted or not readmitted; 
patients who died within 30 days were accounted for to ensure 
accurate readmission calculation. Data collected were not identifiable. 
Data were analysed by PearsoŶ’s chi-square test and phi coefficient 
using IBM SPSS Statistics version 22. 
 
 
 
 
253 patients 
discharged were 
surviving at 30 days 
151 (60%) were 
prescribed 
cardiovascular 
medication 
31 (21%) patients 
prescribed 
cardiovascular 
medication were 
readmitted 
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Figure  2: Patients discharged, prescribed cardiovascular medication, 
and prescribed cardiovascular medication & readmitted. 
